GB0407753D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0407753D0
GB0407753D0 GB0407753A GB0407753A GB0407753D0 GB 0407753 D0 GB0407753 D0 GB 0407753D0 GB 0407753 A GB0407753 A GB 0407753A GB 0407753 A GB0407753 A GB 0407753A GB 0407753 D0 GB0407753 D0 GB 0407753D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0407753A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0407753A priority Critical patent/GB0407753D0/en
Publication of GB0407753D0 publication Critical patent/GB0407753D0/en
Priority to US10/563,668 priority patent/US20060167027A1/en
Priority to DE602004028834T priority patent/DE602004028834D1/en
Priority to CNB2004800257388A priority patent/CN100425240C/en
Priority to MXPA06000114A priority patent/MXPA06000114A/en
Priority to AT04743275T priority patent/ATE478671T1/en
Priority to NZ544458A priority patent/NZ544458A/en
Priority to BRPI0412426-0A priority patent/BRPI0412426A/en
Priority to EP04743275A priority patent/EP1648465B1/en
Priority to KR1020127017256A priority patent/KR20120093411A/en
Priority to KR1020067000464A priority patent/KR20060033782A/en
Priority to JP2006518352A priority patent/JP2007526886A/en
Priority to PCT/GB2004/002932 priority patent/WO2005004870A1/en
Priority to CA2531862A priority patent/CA2531862C/en
Priority to AU2004255022A priority patent/AU2004255022B2/en
Priority to IL172853A priority patent/IL172853A/en
Priority to NO20060307A priority patent/NO333122B1/en
Priority to HK06109909.5A priority patent/HK1089378A1/en
Priority to US12/624,760 priority patent/US20100215773A1/en
Priority to US13/294,152 priority patent/US20120263802A1/en
Ceased legal-status Critical Current

Links

GB0407753A 2003-07-10 2004-04-06 Combination therapy Ceased GB0407753D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0407753A GB0407753D0 (en) 2004-04-06 2004-04-06 Combination therapy
AU2004255022A AU2004255022B2 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
EP04743275A EP1648465B1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
KR1020067000464A KR20060033782A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CNB2004800257388A CN100425240C (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabi
MXPA06000114A MXPA06000114A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability.
AT04743275T ATE478671T1 (en) 2003-07-10 2004-07-07 USE OF THE QUINAZOLINE DERIVATIVE ZD6474 IN COMBINATION WITH PLATINUM COMPOUNDS AND OPTIONAL IONIZING RADIATION IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS AND/OR INCREASED VASCULAR PERMEABILITY
NZ544458A NZ544458A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
BRPI0412426-0A BRPI0412426A (en) 2003-07-10 2004-07-07 use of zd6474 or a pharmaceutically acceptable salt thereof and a platinum antitumor agent, pharmaceutical composition, kit, and method for producing an antiangiogenic and / or vascular permeability reducing effect in a warm-blooded animal
US10/563,668 US20060167027A1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
KR1020127017256A KR20120093411A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
DE602004028834T DE602004028834D1 (en) 2003-07-10 2004-07-07 USE OF THE CHINAZOLIN DERIVATIVE ZD6474 IN COMBINATION WITH PLATIN COMPOUNDS AND OPTIONALLY IONIZED RADIATION IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS AND / OR INCREASED VASPERMEABILITY
JP2006518352A JP2007526886A (en) 2003-07-10 2004-07-07 Use of quinazoline derivative ZD6474 in combination with platinum-based antitumor agents and optional ionizing radiation in the treatment of diseases associated with angiogenesis and / or increased vascular permeability
PCT/GB2004/002932 WO2005004870A1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CA2531862A CA2531862C (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
IL172853A IL172853A (en) 2003-07-10 2005-12-27 Use of the quinazoline derivative zd6474 combined with a platinum anti tumor agent in the manufacture of medicaments for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm blooded animal and pharmaceutical compositions and kits comprising such combination
NO20060307A NO333122B1 (en) 2003-07-10 2006-01-20 Use of 4- (4-bromo-2-fluoroanilino) -6-methoxy-7- (1-methylpiperidin-4-ylmethoxy) quinazoline in combination with platinum compounds in the manufacture of drugs to produce an anticancer or antitumor effect in a warm-blooded animal said as a human as well as pharmaceutical preparation containing the same
HK06109909.5A HK1089378A1 (en) 2003-07-10 2006-09-06 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
US12/624,760 US20100215773A1 (en) 2003-07-10 2009-11-24 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
US13/294,152 US20120263802A1 (en) 2003-07-10 2011-11-10 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0407753A GB0407753D0 (en) 2004-04-06 2004-04-06 Combination therapy

Publications (1)

Publication Number Publication Date
GB0407753D0 true GB0407753D0 (en) 2004-05-12

Family

ID=32320405

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0407753A Ceased GB0407753D0 (en) 2003-07-10 2004-04-06 Combination therapy

Country Status (1)

Country Link
GB (1) GB0407753D0 (en)

Similar Documents

Publication Publication Date Title
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
IL177155A0 (en) Therapeutic combinations
GB0504206D0 (en) Combination therapy
GB0403780D0 (en) Therapeutic agents
GB0509052D0 (en) Combination therapy
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
ZA200709627B (en) Combination therapy
GB0424339D0 (en) Combination therapy
GB0518720D0 (en) Therapeutic combination
GB0417558D0 (en) Novel combination therapy
GB0400193D0 (en) Therapeutic agents
GB0421438D0 (en) Combination therapy
GB0421436D0 (en) Combination therapy
GB0424638D0 (en) Combination therapy
GB0406450D0 (en) Combination therapy
GB0407755D0 (en) Combination therapy
GB0406546D0 (en) Combination therapy
GB0407753D0 (en) Combination therapy
GB0402918D0 (en) Therapeutic agents
GB0400196D0 (en) Therapeutic agents
GB0526121D0 (en) Combination therapy
GB0500658D0 (en) Combination therapy
GB0500659D0 (en) Combination therapy
GB0502949D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)